Lipopolysaccharide and a phorbol ester stimulate secretion of tumor necrosis factor-α from alveolar macrophages through action on overlapping subsets of cells
Michael Taylor, K.E. Hehnke, Cheryl L. Clark
Abstract
Michael Taylor, K.E. Hehnke, Cheryl L. Clark
Abstract
A cell-by-cell analysis of the secretory ability of stimulated, individual alveolar macrophages (AMs) was performed through use of a tumor necrosis factor alpha (TNF-alpha) reverse hemolytic plaque assay. Two functional end points were measured: the percentage of AMs that were TNF-alpha secretors and the cumulative amount of TNF-alpha secreted by AMs (average plaque area, microns 2). Lipopolysaccharide (LPS; 100 micrograms/ml) increased cumulative TNF-alpha release at both 7 and 20 h of incubation. On the other hand, a phorbol ester (phorbol myristate acetate, PMA) stimulated TNF-alpha release at 20 h of incubation but not at 7 h. Under nonstimulated culture conditions, 5-10% of all AMs released detectable TNF-alpha PMA (but not LPS) induced a significant increase in the fraction of AMs capable of releasing TNF-alpha (15.1 +/- 1.1% vs. 9.0 +/- 1.6%, PMA vs. control, P < .05). Differences in the time course of secreted TNF-alpha, together with the recruiting effect of PMA, suggest that LPS and PMA target TNF-alpha-secretory subpopulations of AMs that differ in number and secretory characteristics.
OpenAlex reports 7 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
A cell-by-cell analysis of the secretory ability of stimulated, individual alveolar macrophages (AMs) was performed through use of a tumor necrosis factor alpha (TNF-alpha) reverse hemolytic plaque assay. Two functional end points were measured: the percentage of AMs that were TNF-alpha secretors and the cumulative amount of TNF-alpha secreted by AMs (average plaque area, microns 2). Lipopolysaccharide (LPS; 100 micrograms/ml) increased cumulative TNF-alpha release at both 7 and 20 h of incubation. On the other hand, a phorbol ester (phorbol myristate acetate, PMA) stimulated TNF-alpha release at 20 h of incubation but not at 7 h. Under nonstimulated culture conditions, 5-10% of all AMs released detectable TNF-alpha PMA (but not LPS) induced a significant increase in the fraction of AMs capable of releasing TNF-alpha (15.1 +/- 1.1% vs. 9.0 +/- 1.6%, PMA vs. control, P < .05). Differences in the time course of secreted TNF-alpha, together with the recruiting effect of PMA, suggest that LPS and PMA target TNF-alpha-secretory subpopulations of AMs that differ in number and secretory characteristics.
Key concepts: Lipopolysaccharide, Tumor necrosis factor alpha, Secretion, Incubation, Pulmonary alveolus, Phorbol, Biology, Endocrinology